Foundayo vs Wegovy Pill: Which GLP-1 Pill Fits You?

Last reviewed: 1 October 2026

Which works better?

No one knows, because the trials were separate. In its label trial, Wegovy 25 mg tablets produced an average 13.6% weight reduction at 64 weeks against 2.4% on placebo, and 76.3% of treated patients lost at least 5% of their body weight. Foundayo produced 7.4%, 8.3% and 11.1% at 5.5, 9 and 17.2 mg over 72 weeks, against 2.1% on placebo.

Three cautions apply before you read that as a ranking. The two trials enrolled different patients and ran for different lengths. Both paired the drug with a reduced-calorie diet and increased physical activity. And an average hides a spread; the labels report that some treated patients lost less than 5%. These are not typical individual results, and the figures come from each drug’s own placebo-controlled trial, not from a comparison between the two.

The semaglutide tablet is the same active ingredient as the Wegovy injection, which averaged 14.9% at 68 weeks in its own trial; GLP-1 pill vs injection puts the tablets beside the injections.

How do you take each one?

Both are one tablet a day, and the rules around that tablet are where they differ most. Wegovy tablets must be taken “on an empty stomach in the morning with water (up to 4 ounces)”, swallowed whole, followed by a wait of “at least 30 minutes before eating food, drinking beverages or taking other oral medications”. The label explains why: the tablet is co-formulated with an absorption enhancer called SNAC, absorption happens mainly in the stomach, and only about 1% to 2% of the semaglutide is absorbed.

Foundayo can be taken “with or without food”. Its label says to swallow tablets whole and not to break, crush or chew them. Neither label allows more than one tablet a day.

If your mornings are irregular, or you take other morning medications that cannot wait 30 minutes, that difference will matter more to you than the trial averages.

How fast do you reach the full dose?

Both escalate gradually “to reduce the risk of gastrointestinal adverse reactions”, and both take about three months to reach a maintenance dose.

• Wegovy tablets: 1.5 mg for days 1 to 30, 4 mg for days 31 to 60, 9 mg for days 61 to 90, then 25 mg from day 91.
• Foundayo: 0.8 mg daily, then 2.5 mg and 5.5 mg after at least 30 days on each, with later steps to 9, 14.5 or 17.2 mg.

Self-pay prices rise with these steps, so the dose you start on is the cheapest you will be on. Why the price goes up after the first months covers every manufacturer’s dose tiers.

What do they cost?

Both start at $149 a month at the manufacturers’ self-pay prices, read October 1, 2026. Novo Nordisk prices the Wegovy pill at $149 a month for 1.5 mg, $199 for 4 mg and $299 for 9 mg and 25 mg; one month is one bottle of 30 tablets.

LillyDirect prices Foundayo at $149 a month for 0.8 mg and 2.5 mg, $199 for 5.5 mg and $299 for 9 mg. The 14.5 mg and 17.2 mg doses are $299 “when you refill within 45 days” under Lilly’s Foundayo Self-Pay Journey Program; the page does not state the regular price for those two doses without an on-time refill. Lilly says the 2.5 mg and 5.5 mg prices “are temporarily reduced through December 31, 2026”, and defines a month as 30 days.

At the maintenance dose, then, the two tablets cost the same: $299 a month, with Foundayo’s figure conditional on refilling within 45 days. These prices cover medication only; you still need a prescriber, whose visit is billed separately unless a program bundles it. What GLP-1s cost in 2026 covers insurance, Medicare and the compounded alternatives, and what a GLP-1 program really costs per month adds program fees.

Who can get them?

Both labels indicate the tablet for chronic weight management in adults with obesity, or overweight with at least one weight-related condition, alongside a reduced-calorie diet and increased physical activity; do I qualify for a GLP-1? sets out what those criteria mean in practice and what programs ask. Our quiz shows whether you may meet common criteria; a result is not an approval, and a licensed clinician makes every prescribing decision.

Rybelsus is also an oral semaglutide tablet, but it is approved for type 2 diabetes, not weight loss, and its label says it is “not substitutable on a mg-to-mg basis” with Ozempic tablets. Compounded oral semaglutide sold by telehealth programs is a different product again: it is not FDA-approved, and the FDA says it does not review compounded drugs for safety, effectiveness or quality.

How to choose

Use decision rules, then let a clinician confirm.

• You cannot keep a strict empty-stomach morning routine, or you take other morning medications: Foundayo’s label allows it with or without food; Wegovy tablets need the 30-minute wait.
• The largest label-trial average among the two tablets matters most to you: Wegovy tablets reported 13.6%, with the caution that the trials were not head-to-head.
• You want the same medication as the Wegovy injection in tablet form: that is Wegovy tablets (semaglutide); Foundayo is a different molecule (orforglipron).
• Price is the deciding factor: both start at $149 and both reach $299 at the top doses, so compare the refill condition on Foundayo and whether your plan or Medicare covers either.
• You travel or lack reliable refrigeration: both tablets store at 68°F to 77°F, so neither has an advantage here.

The DoIQualify quiz asks whether you prefer a non-injection option and shows programs that offer one. The compare table marks which programs offer oral, injectable, compounded and brand-name medication.

Foundayo vs Wegovy pill FAQ

This article is informational and not medical advice. A licensed clinician makes every prescribing decision. We may earn a referral fee if you enroll through our links; it does not change scores or positions. Medical disclaimer · How we rankGLP-1 price list